![Michael Bogda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bogda
Directeur/Membre du Conseil chez
Pharmaceutics International, Inc.
Profil
Michael J.
Bogda is currently the Director at Pharmaceutics International, Inc. and an Advisor at Signet Healthcare Partners LLC.
Previously, he held positions as the Director at Apicore LLC from 2014 to 2015, VP-Operations & Facility General Manager at Copley Pharmaceutical, Inc., President & Chief Operating Officer at Lannett Co., Inc. from 2014 to 2016, Executive Vice President-Global Product Supply at Barr Pharmaceuticals, Inc. from 2000 to 2008, Executive VP-Americas Technical Operations at Teva Pharmaceuticals USA, Inc. in 2014, and President & Chief Operating Officer at Barr Laboratories, Inc. He obtained his undergraduate and graduate degrees from Rutgers State University of New Jersey and an MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Michael Bogda
| Sociétés | Poste | Début |
|---|---|---|
Pharmaceutics International, Inc.
 Pharmaceutics International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization that develops clinical and commercial volume aseptic filling, lyophilization & oral solid dose medicines | Directeur/Membre du Conseil | - |
Signet Healthcare Partners LLC
 Signet Healthcare Partners LLC Investment ManagersFinance Signet Healthcare Partners invests in public and private companies across the globe. The fund targets companies operating in the fields of generic & specialty pharmaceuticals, pharmaceuticals services, medical devices and diagnostics. It provides financing for later and growth stage capital requirements with an investment size of USD 10 - 15 million. It makes co-investments and acts as lead investor with majority and minority investments. It also takes a seat on the board of directors. | Consultant / Advisor | - |
Anciens postes connus de Michael Bogda
| Sociétés | Poste | Fin |
|---|---|---|
| LANNETT COMPANY, INC. | President | 03/06/2016 |
Apicore LLC
 Apicore LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/03/2015 |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Corporate Officer/Principal | 01/01/2014 |
Barr Laboratories, Inc.
 Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufacturers, and markets generic and proprietary pharmaceuticals | President | 01/12/2008 |
| BARR PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Formation de Michael Bogda
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Copley Pharmaceutical, Inc.
 Copley Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Lannett Co., Inc.
 Lannett Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies generic pharmaceutical products | Health Technology |
Barr Pharmaceuticals, Inc.
 Barr Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Manufactures & sells generic prescription pharmaceutical products | Health Technology |
Signet Healthcare Partners LLC
Signet Healthcare Partners LLC Investment ManagersFinance Signet Healthcare Partners invests in public and private companies across the globe. The fund targets companies operating in the fields of generic & specialty pharmaceuticals, pharmaceuticals services, medical devices and diagnostics. It provides financing for later and growth stage capital requirements with an investment size of USD 10 - 15 million. It makes co-investments and acts as lead investor with majority and minority investments. It also takes a seat on the board of directors. | Finance |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Health Technology |
Barr Laboratories, Inc.
Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufacturers, and markets generic and proprietary pharmaceuticals | Health Technology |
Pharmaceutics International, Inc.
Pharmaceutics International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization that develops clinical and commercial volume aseptic filling, lyophilization & oral solid dose medicines | Health Technology |
Apicore LLC
Apicore LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
